Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06226168
Other study ID # NdS-II/SP/0512/2023/01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 7, 2024
Est. completion date December 2026

Study information

Verified date May 2024
Source University School of Physical Education, Krakow, Poland
Contact Anna Radon, MSc
Phone +45126831142
Email anna.radon@awf.krakow.pl
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The impact of a proprietary training program in normobaric hypoxia on changes in bone turnover markers as well as carbohydrate and lipid metabolism in premenopausal women falls within the realm of physical culture for an active and healthy society. Within this context, the implementation of a project is supported aiming to: 1. Monitor, support, and promote physical development, fitness, and physical activity in society, by assessing the effects of a proprietary training program in normobaric hypoxia on changes in bone turnover markers as well as carbohydrate and lipid metabolism in premenopausal women. 2. Develop and implement innovative methods, forms, and means of physical activation and training for individuals of various ages, by formulating general assumptions of an endurance-strength training concept under normobaric hypoxia conditions, concerning changes in bone turnover markers as well as carbohydrate and lipid metabolism in premenopausal women. 3. Prevent injuries in physical education and sports, by designing a useful training program for osteoporosis prevention as well as for managing carbohydrate and lipid metabolism disorders in premenopausal women.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date December 2026
Est. primary completion date December 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 50 Years to 59 Years
Eligibility Inclusion Criteria: - No significant cardiovascular, respiratory system diseases and musculoskeletal system, - No contraindications to physical activity. ECG, baseline urinalysis, morphology are required. - T-score within normal limits (+1.0 to -1.0). - Informed consent of the patient to participate in the study. Exclusion Criteria: - Use of hormone replacement therapy (HRT). - Use of substances (cigarettes, alcohol). - Any training (including hypoxia training or exposure) performed in the 6 months prior to the beginning of the intervention - Any other factors determined by the study investigators as unsuitable for participation.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
exercise and environmental conditions
Participants will perform endurance-strength training for 4 weeks in a variety of environmental conditions. Somatic indices and quantitative indicators of bone mass (bone mineral density) will be measured both before and after the training period. Before the first training day and the day after the last training day, blood will be drawn for biochemical analysis.
exercise and environmental conditions
Passive exposure to normobaric hypoxia conditions. No training intervention. There will be a measurement of selected somatic indices and a quantitative measurement of bone mass indices (bone mineral density). A blood draw for biochemical analysis will be performed.

Locations

Country Name City State
Poland University School of Physical Education in Cracow Krakow
Poland University School of Physical Education in Cracow Kraków

Sponsors (2)

Lead Sponsor Collaborator
University School of Physical Education, Krakow, Poland Ministry of Education and Science,Poland

Country where clinical trial is conducted

Poland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood analysis- part 1 Bone turnover markers: bone-specific alkaline phosphatase (ng/ml), osteocalcin (ng/ml), N-terminal telopeptide of type I collagen (ng/ml), osteoprotegerin (ng/ml), 25-hydroxyvitamin D3 metabolite (ng/ml). Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 2 Hormones of lipid metabolism: adiponectin (µg/mL) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 3 Hormones of lipid metabolism: lipid profile (mg/dL) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 4 Hormones of lipid metabolism: lipoprotein atherogenicity index (no unit) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 5 Hormones of carbohydrate metabolism: glucose (mg/dL) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 6 Hormones of carbohydrate metabolism: insulin (IU/mL), leptin (IU/mL), ghrelin (IU/mL) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 7 Thyroid hormones: Thyroid Stimulating Hormone (IU/L) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 8 Vitamins: Vitamin D (ng/mL) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 9 Plasma volume changes (ml/kg) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 10 Rheology: viscosity (Pa·s), viscoelasticity (Pa·s) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 11 Rheology: shear rate (s-¹) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 12 Rheology: shear stress (Pa), elastic modulus (Pa) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 13 Blood biochemistry: erythrocytes (million/µL) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 14 Blood biochemistry: leukocytes (thousand/µL), platelets (thousand/µL) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 15 Blood biochemistry: hemoglobin (g/dL) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 16 Blood biochemistry: hematocrit (%), red cell distribution width (%) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 17 Blood biochemistry: mean corpuscular volume (femtoliter) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 18 Blood biochemistry: mean corpuscular hemoglobin (picogram) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 19 Blood biochemistry: mean corpuscular hemoglobin concentration (g/dL), albumin (g/dL) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 20 Blood biochemistry: creatinine (mg/dL), bilirubin (mg/dL), blood urea nitrogen (mg/dL) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 21 Blood biochemistry: erythrocyte sedimentation rate (mm/h) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 22 Blood biochemistry: alanine aminotransferase (U/L), aspartate aminotransferase (U/L) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Blood analysis- part 23 Blood biochemistry: ferritin (ng/mL) Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
Primary Bone mass- part 1 To identify quantitative indicators of bone mass, a densitometric study will be performed using dual energy X-ray absorptiometry (DXA). Selected quantitative indicators of bone mass will be measured: bone mineral density (g/cm^2). 1 day before and 1 day after the training program. Training will last 4 weeks.
Primary Bone mass- part 2 To identify quantitative indicators of bone mass, a densitometric study will be performed using dual energy X-ray absorptiometry (DXA). Selected quantitative indicators of bone mass will be measured: T-score (no unit). 1 day before and 1 day after the training program. Training will last 4 weeks.
Primary Bone mass- part 3 To identify quantitative indicators of bone mass, a densitometric study will be performed using dual energy X-ray absorptiometry (DXA). Selected quantitative indicators of bone mass will be measured: Z-score (no unit). 1 day before and 1 day after the training program. Training will last 4 weeks.
Primary Bone mass- part 4 To identify quantitative indicators of bone mass, a densitometric study will be performed using dual energy X-ray absorptiometry (DXA). Selected quantitative indicators of bone mass will be measured: relative skeletal-muscular index (kg/m^2). 1 day before and 1 day after the training program. Training will last 4 weeks.
Primary Somatic indicators- part 1 A densitometry study using dual energy X-ray absorptiometry (DXA) will be conducted to determine body composition: lean body mass (kg). 1 day before and 1 day after the training program. Training will last 4 weeks.
Primary Somatic indicators- part 2 A densitometry study using dual energy X-ray absorptiometry (DXA) will be conducted to determine body composition: percentage of body fat (%). 1 day before and 1 day after the training program. Training will last 4 weeks.
Primary Somatic indicators- part 3 A densitometry study using dual energy X-ray absorptiometry (DXA) will be conducted to determine body composition: fat mass (kg). 1 day before and 1 day after the training program. Training will last 4 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04498598 - Structural Modification In Supraglottic Airway Device N/A
Completed NCT05532670 - N600X Low Saturation Accuracy Validation
Enrolling by invitation NCT04106401 - Intravascular Volumes in Hypoxia During Antarctic Confinement N/A
Recruiting NCT05883137 - High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
Not yet recruiting NCT05817448 - Hypoxia-induced Autophagy in the Pathogenesis of MAP
Recruiting NCT02661152 - DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC. Phase 3
Terminated NCT02801162 - Evaluation of Accuracy and Precision of a New Arterial Blood Gas Analysis System Blood in Comparison With the Reference Standard N/A
Completed NCT02943863 - Regional Ventilation During High Flow Nasal Cannula and Conventional Nasal Cannula in Patients With Hypoxia N/A
Not yet recruiting NCT02201875 - Intrinsic Periodic Pattern of Breathing N/A
Completed NCT01922401 - Inverse Ratio Ventilation on Bariatric Operation N/A
Completed NCT02105298 - Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study) N/A
Active, not recruiting NCT01681238 - Goal-directed Therapy in High-risk Surgery N/A
Completed NCT01463527 - Using Capnography to Reduce Hypoxia During Pediatric Sedation N/A
Completed NCT01507623 - Value of Capnography During Nurse Administered Propofol Sedation (NAPS) N/A
Withdrawn NCT00638040 - The Gene Expression Studies of the Role of Tumor Microenvironments in Tumor Progression N/A
Active, not recruiting NCT06097754 - Intermittent Exogenous Ketosis (IEK) at High Altitude N/A
Completed NCT04589923 - The VISION-Acute Study
Completed NCT05044585 - Evaluation of RDS MultiSense® in Desaturation Analysis in Healthy Volunteers N/A
Completed NCT03659513 - The Effect of ECMO on the Pharmacokinetics of the Drugs and Their Clinical Efficacy
Completed NCT03221387 - Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD Outpatients N/A